ClinicalTrials.gg
Status unknownNCT05383430Updated May 20, 2022

Prevalence of Stuttering in Children With ADHD at Sohag University Hospital

An observational study in ADHD Children With Stuttering, sponsored by Sohag University. Status unknown at 1 site in Egypt. Open to participants aged 6 Years to 18 Years. Per ClinicalTrials.gov, last updated 2022-05-20.

Sponsored by Sohag University · Observational

The sponsor has not verified this record recently (last verified May 2022), so the status shown — last known as Not yet recruiting — may be out of date.
Study type
Observational
Model
Cohort
Time perspective
Cross-sectional
Enrollment
50
Ages
6 Years to 18 Years
Sex
All
01

Study summary

The majority of the latest research suggests that stuttering is associated with significantly elevated levels of trait and social anxiety. The prevalence of children who stutter and have attention deficit/ hyperactivity disorder (ADHD) ranges from 4 to 26%. About 10-20% of children who stutter might show ADHD.

Gender ( male) is the dominant risk factor for stuttering, as also applies to other neurodevelopmental disorders. Examples include attention deficit hyperactive disorder (ADHD), conduct disorder, tics and the Gilles de la Tourette syndrome (GTS). These neurodevelopmental disorders are the second -most prominent set of comorbidities with stuttering.

Attention-deficit hyperactivity disorder (ADHD) and stuttering share many characteristics in addition to temperament . A complex interplay of neural differences, with genetic and environmental components, has been reported as a possible cause of both disorders. In addition, both may appear more frequently in boys than in girls . Furthermore, it is emphasized that childhood stuttering can be accompanied by aspects of ADHD . Likewise, children exhibiting signs of ADHD more frequently display speech disfluencies than their peers.

It is suggested that children with stuttering and those without stuttering will display different profiles in terms of temperament, certain aspects of ADHD, and some types of anxiety. In addition, it is to be expected that there will be some correlations between these variables in children who stutter. However, it is not possible to draw definite conclusions about this issue that could be generalized to all children who stutter. Furthermore, there are very few studies that deal with combinations of these variables .

02

Conditions studied

  • ADHD Children With Stuttering
03

In context

Attention Deficit Disorder with Hyperactivity

1,817 studies on the registry are indexed under Attention Deficit Disorder with Hyperactivity; 296 are open to participants now.

This study's planned enrollment of 50 is below the median of 127 across 329 observational studies indexed under Attention Deficit Disorder with Hyperactivity.

Browse Attention Deficit Disorder with Hyperactivity studies →

Lead sponsor

Sohag University is the lead sponsor of 1,230 studies on the registry; 636 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
6 Years to 18 Years
Sexes eligible
All
Sampling method
Non-probability sample

Study population

ADHD children with stuttering -: Cross sectional observational study. Period of the study: one year from the date of acceptance of the protocol.

Place of the study: at Neuropsychiatriy and Phoniatric units at Sohag University Hospital.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • All children with ADHD

Exclusion criteria

Exclusion Criteria:

  • 1-Children ageed below 6 years old. 2- children with ADHD with other behavioral and neurological disorders.
05

Study design

Observational model
Cohort
Time perspective
Cross-sectional
Enrollment
50 participants (estimated)
Patient registry
No

Interventions

  • Diagnostic test: Conners rating scale-Stanford-Binet Intelligence Scales- stuttering severity index third edition (SSI-3) .

    Questionaire tests for ADHD -IQ-Stuttering severity assessment

06

What researchers measure

Primary outcomes

  1. Prevalence of stuttering in ADHD children

    assessment of stuttering in ADHD children

    Time frame: 1 year

07

Study locations

1 site
  • Sohag University Hospital
    Sohag, Egypt
    • Osama R ELsheref, professor · Contact
08

References and documents

Publications

  • Riley GD. A stuttering severity instrument for children and adults. J Speech Hear Disord. 1972 Aug;37(3):314-22. doi: 10.1044/jshd.3703.314. No abstract available. PubMed 5057250 ↗
  • Healey EC, Reid R. ADHD and stuttering: a tutorial. J Fluency Disord. 2003 Summer;28(2):79-92; quiz 93. doi: 10.1016/s0094-730x(03)00021-4. PubMed 12809746 ↗
  • Lan J, Song M, Pan C, Zhuang G, Wang Y, Ma W, Chu Q, Lai Q, Xu F, Li Y, Liu L, Wang W. Association between dopaminergic genes (SLC6A3 and DRD2) and stuttering among Han Chinese. J Hum Genet. 2009 Aug;54(8):457-60. doi: 10.1038/jhg.2009.60. Epub 2009 Jul 10. PubMed 19590515 ↗
  • Verkuijl N, Perkins M, Fazel M. Childhood attention-deficit/hyperactivity disorder. BMJ. 2015 May 20;350:h2168. doi: 10.1136/bmj.h2168. No abstract available. PubMed 25994532 ↗

Individual participant data

Plan to share: Yes

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Start is estimated for Jun 2022; primary completion for Jun 2023, 12 months later.

How these figures are worked out, and which studies are left out of them.

Registered
May 16, 2022
First posted
May 20, 2022
StartEst.
Jun 2022
Primary completionEst.
Jun 2023
CompletionEst.
Jun 2023
Last update
May 20, 2022
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on May 20, 2022, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05383430
Lead sponsor
Sohag University
Responsible party
Samar Medhat Kamal Eldin (resident doctor at pediatric department, Sohag University) — Principal investigator
First posted
May 20, 2022
Start date
Jun 2022 (estimated)
Primary completion
Jun 2023 (estimated)
Completion
Jun 2023 (estimated)
Last update
May 20, 2022

Study contacts

Samar M kamal eldein, resident doctor
Contact
samermedhat@med.sohag.edu.eg
01228011393
Abdelrahim a Sadek, professor
Contact

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in May 2022. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion